focus -WSS

focus

author：comprehensive 2025-08-19 18:04:31 - browse：38

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Physician subsidies by hospitals soar in wake of No Surprises Act

WSS

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Maui funeral service workers on devastation of fires: 'I'm in shock'

Target recalls 2.2 million additional candles due to laceration, burn hazards

The history of OxyContin, told through Purdue Pharma documents

Why Sanofi got shellacked over its spinoff

Faced with fears of OxyContin misuse, sales reps touted its safety

leisure time

focus

hotspot

Peter Hotez and the public health issue of online harassment

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

George Santos makes 1st court appearance after pleading not guilty to 13 counts

WHO may add ‘noma' to its list of neglected tropical diseases

Supreme Court strikes down use of affirmative action

Timeline: Special counsel's investigation into Trump's handling of classified documents

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: What happened with Sarepta's Duchenne data

Virginia high school admissions case could be legal follow

First Opinion Podcast: How to protect health care in times of war

entertainment

Physician subsidies by hospitals soar in wake of No Surprises Act

The pink breast cancer awareness ribbon needs a redesign

Senate panel to vote on hospitals, PBMs, prisoner care

FDA has safety concerns on CRISPR

GOP presidential candidates start declaring their loyalty

Pharma budget tightening trickles down to Doximity

explore

knowledge

explore

hotspot